This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

BRAVADA International Says It Will Not Issue New Common Stock For Capital Considerations As Long As It Perceives Its Stock Price To Be Undervalued

BRAVADA International Ltd. ( www.OnlyLeggings.com) (Pink Sheets:BRAV) announced today that it has no plans to issue any new common stock for capital considerations as long as it perceives its stock price to be undervalued. The Company has made this determination from a number of criteria. First and foremost is that free cash-flow from operations continues to increase and significant growth can be derived from this alone as demonstrated in its fiscal year 2012 where the Company experienced 250% revenue growth and yet did not issue even one share of its common stock in 2012.

The other consideration for not diluting its common stock is from a pure evaluation metric. The Company believes that given its valuation, growth rate, margins and forward-looking value, a sales multiple of 8-12 times can be argued easily and that any dilution significantly below the Company’s evaluation and growth potential would harm the Company and shareholders. Fiscal year 2012 revenue was $3,476,066.50, and the Company believes that fiscal year 2013 could see the same kind of growth rate (250%) as 2012. With a current market capitalization of just over one (1) times 2012 revenue and one-half (0.5) 2013 revenue, it would be irresponsible to issue common stock for capital at this evaluation. Shareholders should expect that most, if not all, profits will go to growing BRAVADA International whether it is to increase our retail store footprint or growing online sales, profits will be reinvested into growth.

“We are and always will make determinations that make sense for shareholders to ensure maximum value is achieved in our common stock,” replied Danny Alex, CEO of BRAVADA International. “To issue common stock for capital at a market capitalization that we feel significantly undervalues the Company harms all shareholders. New investors must acquire a position, big or small, from the open market as the Company will not issue new common stock for capital at these evaluations.”

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,691.83 -38.28 -0.22%
S&P 500 2,070.21 -6.57 -0.32%
NASDAQ 4,992.4390 -16.7750 -0.33%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs